Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Drake Scott William, Chairman & CEO. Officer active across 3 companies, notably AtriCure, Inc.. In total, 16 filings have been published. Breakdown: 2 buys · 1 sell. Total volume traded: €672k. Activity tracked since 7 May 2021. The latest transaction was disclosed on 18 July 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Drake Scott William
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
38,641 shares@ US$8.98100.0% of flowCommon StockSEC:0001209191-21-031479:0
16 of 16 declarations
About Drake Scott William
Drake Scott William is President and Chief Executive Officer and a declarant in 16 filings in total. In the 16 sampled filings, covering the period from 2021-05-11 to 2023-07-20, buys amount to EUR 539005 and sells to EUR 133427, with the modal transaction nature listed as tax withholding. He is also a director of ViewRay, Inc., Paragon 28, Inc. and AtriCure, Inc., and his largest filings concern ViewRay, Inc.